Aceragen, Inc.
ACGNDelisted Aug 16, 2023- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000861838
Aceragen, Inc. was delisted on Aug 16, 2023; its insiders filed their last Form 4 on Aug 11, 2023; 20 institutions reported holding it in 13F filings for Q2 2023, worth $269.5K in total; no superinvestor held it.
13F holders, Q3 2023
Institutional positions in Aceragen, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
ACGN is no longer listed, and 13F filings after Q2 2023 list far fewer holders. See Q2 2023
- Institutional holders
- 3
- −17 vs. Q2 2023
- Shares held
- 4.35K
- −161.0K (−97.4%) vs. Q2 2023
- Total value
- $22
- −$269.5K (−100.0%) vs. Q2 2023
- New holders
- 0
- 0 more added
- Sold out
- 17
- 0 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ACGN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 3 | $0 |
| Q1 2024 | 3 | $0 |
| Q4 2023 | 3 | $0 |
| Q3 2023 | 3 | $22 |
| Q2 2023 | 20 | $269.5K |
| Q1 2023 | 19 | $384.8K |
| Q4 2022 | 32 | $1.13M |
| Q3 2022 | 34 | $1.30M |
| Q2 2022 | 33 | $1.65M |
| Q1 2022 | 31 | $1.86M |
| Q4 2021 | 34 | $2.42M |
| Q3 2021 | 47 | $6.39M |
| Q2 2021 | 48 | $7.60M |
| Q1 2021 | 57 | $12.8M |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Aceragen, Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Parallel Advisors, LLC | 58 | $22 | 0.00% | 00.0% | Unchanged |
| Hollencrest Capital Management | 3,999 | $0 | 0.00% | 00.0% | Unchanged |
| Caldwell Sutter Capital, Inc. | 294 | $0 | 0.00% | 00.0% | Unchanged |
| Vanguard Group Inc | 0 | $0 | 0.00% | −74,170−100.0% | Sold out |
| BlackRock Inc. | 0 | $0 | 0.00% | −25,214−100.0% | Sold out |
| Geode Capital Management, LLC | 0 | $0 | 0.00% | −23,342−100.0% | Sold out |
| State Street Corp | 0 | $0 | 0.00% | −11,653−100.0% | Sold out |
| Credit Agricole S A | 0 | $0 | 0.00% | −11,521−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −7,126−100.0% | Sold out |
| Morgan Stanley | 0 | $0 | 0.00% | −4,860−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −1,709−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −1,047−100.0% | Sold out |
| The PNC Financial Services Group, Inc. | 0 | $0 | 0.00% | −191−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −58−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −36−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −30−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −25−100.0% | Sold out |
| Signaturefd, LLC | 0 | $0 | 0.00% | −11−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −10−100.0% | Sold out |
| NewSquare Capital LLC | 0 | $0 | 0.00% | −4−100.0% | Sold out |